|
|
Barbara Davis Center for Childhood Diabetes
Publications
2005
Ahmed Z, Lockhart CH, Weiner M, Klingensmith G. Advances in diabetic management: implications for anesthesia. Anesth Analg. 2005 Mar;100(3):666-9. [PubMed]
Alkhateeb A, Fain PR, Spritz RA. Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo. J Invest Dermatol. 2005 Aug;125(2):388-91. [PubMed]
Aly T, Devendra D, Eisenbarth GS. Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes. Am J Ther. 2005 Nov-Dec;12(6):481-90. Review. [PubMed]
Aly T, Ide A, Humphrey K, Barker JM, Steck AK, Erlich H, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J Autoimmun. 2005;25 Suppl:40-5. [PubMed]
Ateya DA, Sachs F, Gottlieb PA, Besch S, Hua SZ. Volume cytometry: microfluidic sensor for high-throughput screening in real time. Anal Chem. 2005 Mar 1;77(5):1290-4. [PubMed]
Babaya N, Nakayama M, Eisenbarth GS. The stages of type 1A diabetes. Ann N Y Acad Sci. 2005 Jun;1051:194-204. Review. [PubMed]
Barker JM. Polyendocrine autoimmunity. Curr Diab Rep. 2005 Apr;5(2):84-90. [PubMed]
Barker JM, Ide A, Hostetler C, Yu L, Miao D, Fain PR, Eisenbarth GS, Gottlieb PA. Endocrine and immunogenetic testing in individuals with type 1 diabetes and 21-hydroxylase autoantibodies: Addison's disease in a high-risk population. J Clin Endocrinol Metab. 2005 Jan;90(1):128-34. [PubMed]
Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, Hoffenberg E, Nelson JC, Gottlieb PA, Rewers M, Eisenbarth GS. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care. 2005 Apr;28(4):850-5. [PubMed]
Basu A, Service FJ, Yu L, Heser D, Ferries LM, Eisenbarth G. Insulin autoimmunity and hypoglycemia in seven white patients. Endocr Pract. 2005 Mar-Apr;11(2):97-103. [PubMed]
Beilke JN, Kuhl NR, Van Kaer L, Gill RG. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med. 2005 Oct;11(10):1059-65. [PubMed]
Carniel E, Taylor MR, Sinagra G, Di Lenarda A, Ku L, Fain PR, Boucek MM, Cavanaugh J, Miocic S, Slavov D, Graw SL, Feiger J, Zhu XZ, Dao D, Ferguson DA, Bristow MR, Mestroni L. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation. 2005 Jul 5;112(1):54-9. [PubMed]
Chase HP. Don't take away my pump! Switching to injections may cause problems. Diabetes Forecast. 2005 Sep;58(9):55-6. [PubMed]
Chase HP, Beck R, Tamborlane W, Buckingham B, Mauras N, Tsalikian E, Wysocki T, Weinzimer S, Kollman C, Ruedy K, Xing D. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care. 2005 May;28(5):1101-6. [PubMed]
Chase HP, Eisenbarth GS. Diabetes mellitus. In: Hay WW Jr., Hayward AR, Levin ML, Sondheimer JM, Deterding RR, editors. Current pediatric diagnosis and treatment. 17th ed. New York: McGraw Hill; 2005.
Devendra D, Jasinski J, Melanitou E, Nakayama M, Li M, Hensley B, Paronen J, Moriyama H, Miao D, Eisenbarth GS, Liu E. Interferon-alpha as a mediator of polyinosinic:polycytidylic acid-induced type 1 diabetes. Diabetes. 2005 Sep;54(9):2549-56. [PubMed]
Dixon B, Chase HP, Burdick J, Fiallo-Scharer R, Walravens P, Klingensmith G, Rewers M, Garg SK. Use of insulin glargine in children under age 6 with type 1 diabetes. Pediatr Diabetes. 2005 Sep;6(3):150-4. [PubMed]
Eisenbarth GS. Statin treatment of patients with diabetes. Curr Diab Rep. 2005 Apr;5(2):83. [PubMed]
Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D'Alessio DA. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J Clin Endocrinol Metab. 2006 Jan;91(1):185-91. [PubMed]
Emery LM, Babu S, Bugawan TL, Norris JM, Erlich HA, Eisenbarth GS, Rewers M. Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates. Pediatr Diabetes. 2005 Sep;6(3):136-44. [PubMed]
Fain PR, McFann KK, Taylor MR, Tison M, Johnson AM, Reed B, Schrier RW. Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int. 2005 Apr;67(4):1256-67. [PubMed]
Faubel S, Ljubanovic D, Poole B, Dursun B, He Z, Cushing S, Somerset H, Gill RG, Edelstein CL. Peripheral CD4 T-cell depletion is not sufficient to prevent ischemic acute renal failure. Transplantation. 2005 Sep 15;80(5):643-9. [PubMed]
Ferucci ED, Majka DS, Parrish LA, Moroldo MB, Ryan M, Passo M, Thompson SD, Deane KD, Rewers M, Arend WP, Glass DN, Norris JM, Holers VM. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2005 Jan;52(1):239-46. [PubMed]
Fiallo-Scharer R; Diabetes Research in Children Network Study Group. Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab. 2005 Jun;90(6):3387-91. [PubMed]
Garg SK. New insulin analogues. Diabetes Technol Ther. 2005 Oct;7(5):813-7. [PubMed]
Garg SK, Ellis SL, Ulrich H. Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes. Expert Opin Pharmacother. 2005 Apr;6(4):643-51. [PubMed]
Garg SK, Rosenstock J, Ways K. Optimized Basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with Basal insulin glargine. Endocr Pract. 2005 Jan-Feb;11(1):11-7. [PubMed]
Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005. Immunol Rev. 2005 Apr;204:232-49. Review. [PubMed]
Geng DG, Liu SY, Steck A, Eisenbarth G, Rewers M, She JX. Comment on: Biason-Lauber A, Boehm B, Lang-Muritano M, et al (2005) Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900-905. Diabetologia. 2006 Jan;49(1):215-6. [PubMed]
Grazia TJ, Gill RG, Gelhaus HC Jr, Doan AN, Sleater ML, Pietra BA. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival. J Heart Lung Transplant. 2005 Sep;24(9):1410-4. [PubMed]
Heise CE, Pahuja A, Hudson SC, Mistry MS, Putnam AL, Gross MM, Gottlieb PA, Wade WS, Kiankarimi M, Schwarz D, Crowe P, Zlotnik A, Alleva DG. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. J Pharmacol Exp Ther. 2005 Jun;313(3):1263-71. [PubMed]
Homann D, von Herrath MG. "Natural" and "induced" regulatory T cells - purpose and problems associated with an emerging distinction. In: Taams LS. Akbar AN, Wauben MWM, editors. Regulatory T cells in inflammation: progress in inflammation research. Basel: Birkhäuser Verlag; 2005.
Ide A, Babu SR, Robles DT, Wang T, Erlich HA, Bugawan TL, Rewers M, Fain PR, Eisenbarth GS. "Extended" A1, B8, DR3 haplotype shows remarkable linkage disequilibrium but is similar to nonextended haplotypes in terms of diabetes risk. Diabetes. 2005 Jun;54(6):1879-83. [PubMed]
Ide A, Babu SR, Robles DT, Wang T, Erlich HA, Bugawan TL, Rewers M, Fain PR, Eisenbarth GS. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives. J Clin Immunol. 2005 Jul;25(4):303-8. [PubMed]
Izuora KE, Chase HP, Jackson WE, Coll JR, Osberg IM, Gottlieb PA, Rewers MJ, Garg SK. Inflammatory markers and diabetic retinopathy in type 1 diabetes. Diabetes Care. 2005 Mar;28(3):714-5. [PubMed]
Jasinski JM, Eisenbarth GS. Hypothesis for the pathogenesis of type 1A diabetes. Drugs Today (Barc). 2005 Feb;41(2):141-9. Review. [PubMed]
Jasinski JM, Eisenbarth GS. Insulin as a primary autoantigen for type 1A diabetes. Clin Dev Immunol. 2005 Sep;12(3):181-6. Review. [PubMed]
Jensen JN, Cameron E, Garay MV, Starkey TW, Gianani R, Jensen J. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology. 2005 Mar;128(3):728-41. [PubMed]
Kupfer TM, Crawford ML, Pham K, Gill RG. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo. J Immunol. 2005 Aug 15;175(4):2309-16. [PubMed]
Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, Spritz RA. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005 Aug;18(4):300-5. [PubMed]
Libby P, Nathan DM, Abraham K, Brunzell JD, Fradkin JE, Haffner SM, Hsueh W, Rewers M, Roberts BT, Savage PJ, Skarlatos S, Wassef M, Rabadan-Diehl C; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation. 2005 Jun 28;111(25):3489-93. [PubMed]
Limesand SW, Jensen J, Hutton JC, Hay WW Jr. Diminished beta-cell replication contributes to reduced beta-cell mass in fetal sheep with intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol. 2005 May;288(5):R1297-305. [PubMed]
Liu E, Li M, Bao F, Miao D, Rewers MJ, Eisenbarth GS, Hoffenberg EJ. Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children. J Pediatr. 2005 Apr;146(4):494-9. [PubMed]
Liu E, Rewers M, Eisenbarth GS. Genetic testing: who should do the testing and what is the role of genetic testing in the setting of celiac disease? Gastroenterology. 2005 Apr;128(4 Suppl 1):S33-7. Review. [PubMed]
Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J, Ehrlich J, Garg S, Eckel RH, Rewers MJ. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care. 2005 Feb;28(2):301-6. [PubMed]
Maahs DM, Maniatis AK, Nadeau K, Wadwa RP, McFann K, Klingensmith GJ. Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. J Pediatr. 2005 Oct;147(4):544-6. [PubMed]
Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson JE, Ehrlich J, Eckel RH, Rewers M. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation. 2005 Feb 15;111(6):747-53. [PubMed]
Maniatis AK, Goehrig SH, Gao D, Rewers A, Walravens P, Klingensmith GJ. Increased incidence and severity of diabetic ketoacidosis among uninsured children with newly diagnosed type 1 diabetes mellitus. Pediatr Diabetes. 2005 Jun;6(2):79-83. [PubMed]
Maniatis AK, Simmons JH, Zeitler PS. Hypothalamic obesity in a patient with craniopharyngioma: dysregulation of neurohormonal control of energy balance. Curr Opin Pediatr. 2005 Apr;17(2):275-9. [PubMed]
Murakawa T, Kerklo MM, Zamora MR, Wei Y, Gill RG, Henson PM, Grover FL, Nicolls MR. Simultaneous LFA-1 and CD40 ligand antagonism prevents airway remodeling in orthotopic airway transplantation: implications for the role of respiratory epithelium as a modulator of fibrosis. J Immunol. 2005 Apr 1;174(7):3869-79. [PubMed]
Nadeau KJ, Klingensmith G, Zeitler P. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr. 2005 Jul;41(1):94-8. [PubMed]
Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature. 2005 May 12;435(7039):220-3. [PubMed]
Nakayama M, Babaya N, Miao D, Sikora K, Elliott JF, Eisenbarth GS. Thymic expression of mutated B16:A preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout. J Autoimmun. 2005 Nov;25(3):193-8. Epub 2005 Nov 14. [PubMed]
Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, Haas JE, Emery LM, Sokol RJ, Erlich HA, Eisenbarth GS, Rewers M. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA. 2005 May 18;293(19):2343-51. [PubMed]
Paterson AD, Magistroni R, He N, Wang K, Johnson A, Fain PR, Dicks E, Parfrey P, St George-Hyslop P, Pei Y. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2005 Mar;16(3):755-62. [PubMed]
Pinhas-Hamiel O, Zeitler P. Advances in epidemiology and treatment of type 2 diabetes in children. Adv Pediatr. 2005;52:223-59. [PubMed]
Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005 May;146(5):693-700. [PubMed]
Putnam AL, Vendrame F, Dotta F, Gottlieb PA. CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun. 2005 Feb;24(1):55-62. [PubMed]
Rayat GR, Gill RG. Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB. Diabetes. 2005 Feb;54(2):443-51. [PubMed]
Redondo MJ, Babu S, Yu L, Fernando M, Smith TM, Fain PR, Eisenbarth GS. Concordance rate of 90% at 15 years for islet autoimmunity in initially discordant monozygotic twins of T1DM patients carrying HLA DR3-DR4, and preliminary data for overall long-term concordance exceeding 95%. Diabetes. 2005;54(Suppl 1):A274.
Redondo MJ, Hawa M, Bugawan TL, Babu S, Yu L, Yang F, Fernando M, Alejandrino I, Fain PR, Erlich HA, Eisenbarth GS, Leslie RDG. Polymorphisms in the vitamin D receptor, alone and in combination with HLA DQ, improve our prediction of progression to T1DM in monozygotic twins of patients from the United States and the United Kingdom. Diabetes. 2005;54(Suppl 1):A274.
Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology. 2005 Apr;128(4 Suppl 1):S47-51. [PubMed]
Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, Kahn R, Kreuwel HT. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity. 2005 Aug;23(2):115-26. Review. [PubMed]
Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005 Jan;28(1):186-212. [PubMed]
Simmons JH, Miller E, Travers S. Hyponatremia in a neonate: a case report. Curr Opin Pediatr. 2005 Aug;17(4):525-7. [PubMed]
Simmons JH, Zeitler PS, Fenton LZ, Abzug MJ, Fiallo-Scharer RV, Klingensmith GJ. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature. Pediatr Diabetes. 2005 Dec;6(4):234-8. [PubMed]
Singh VK, Srinivasan V, Seed TM, Jackson WE, Miner VE, Sree Kumar K. Radioprotection by N-palmitoylated nonapeptide of human interleukin-1beta. Peptides. 2005 Mar;26(3):413-8. [PubMed]
Steck AK, Barriga KJ, Emery LM, Fiallo-Scharer RV, Gottlieb PA, Rewers MJ. Secondary attack rate of type 1 diabetes in Colorado families. Diabetes Care. 2005 Feb;28(2):296-300. [PubMed]
Steck AK, Bugawan TL, Valdes AM, Emery LM, Blair A, Norris JM, Redondo MJ, Babu SR, Erlich HA, Eisenbarth GS, Rewers MJ. Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes. 2005 Aug;54(8):2482-6. [PubMed]
Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. Diabetes Care. 2005 May;28(5):1068-76. [PubMed]
Tansey MJ, Beck RW, Buckingham BA, Mauras N, Fiallo-Scharer R, Xing D, Killman C, Tamborlane WV, Ruedy KJ; The Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technol Ther. 2005 Feb;7(1):109-14. [PubMed]
Taylor M, Johnson AM, Tison M, Fain P, Schrier RW. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications. Am J Kidney Dis. 2005 Sep;46(3):415-23. [PubMed]
Taylor MR, Slavov D, Gajewski A, Vlcek S, Ku L, Fain PR, Carniel E, Di Lenarda A, Sinagra G, Boucek MM, Cavanaugh J, Graw SL, Ruegg P, Feiger J, Zhu X, Ferguson DA, Bristow MR, Gotzmann J, Foisner R, Mestroni L; Familial Cardiomyopathy Registry Research Group. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat. 2005 Dec;26(6):566-74. [PubMed]
Tiberti C, Verrienti A, Fiore B, Yu L, Eisenbarth GS, Dotta F, Di Mario U. IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes. Clin Immunol. 2005 Jun;115(3):260-7. [PubMed]
Tsalikian E, Mauras N, Beck RW, Tamborlane WV, Janz KF, Chase HP, Wysocki T, Weinzimer SA, Buckingham BA, Kollman C, Xing D, Ruedy KJ; Diabetes Research In Children Network Direcnet Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr. 2005 Oct;147(4):528-34. [PubMed]
Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, Eckel RH, Rewers M. Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care. 2005 May;28(5):1051-6. [PubMed]
Wadwa RP, Kinney GL, Ogden L, Snell-Bergeon JK, Maahs DM, Cornell E, Tracy RP, Rewers M. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol. 2006;38(5-6):996-1003. [PubMed]
Wasmeier C, Burgos PV, Trudeau T, Davidson HW, Hutton JC. An extended tyrosine-targeting motif for endocytosis and recycling of the dense-core vesicle membrane protein phogrin. Traffic. 2005 Jun;6(6):474-87. [PubMed]
Weinzimer SA, Beck RW, Chase HP, Buckingham BA, Tamborlane WV, Kollman C, Coffey J, Xing D, Ruedy KJ; Diabetes Research in Children Network Study Group. Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technol Ther. 2005 Oct;7(5):675-80; discussion 681-3. [PubMed]
Yeung EW, Whitehead NP, Suchyna TM, Gottlieb PA, Sachs F, Allen DG. Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse. J Physiol. 2005 Jan 15;562(Pt 2):367-80. [PubMed]
Zeitler PS, Travers SH, Barker J, Nadeau K, Kappy MS. Endocrine disorders. In: Hay WW Jr., Hayward AR, Levin ML, Sondheimer JM, Deterding RR, editors. Current pediatric diagnosis and treatment. 17th ed. New York: McGraw Hill; 2005.
2004
Aly T, Devendra D, Barker J, Liu E, Yu L, Eisenbarth GS. Heterophile antibodies masquerade as interferon-alpha in subjects with new-onset type 1 diabetes. Diabetes Care. 2004 May;27(5):1205-6. [PubMed]
Azam A, Eisenbarth GS. Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes. Expert Opin Biol Ther. 2004 Oct;4(10):1569-75. [PubMed]
Bailey-Wilson JE, Amos CI, Pinney SM, Petersen GM, de Andrade M, Wiest JS, Fain P, Schwartz AG, You M, Franklin W, Klein C, Gazdar A, Rothschild H, Mandal D, Coons T, Slusser J, Lee J, Gaba C, Kupert E, Perez A, Zhou X, Zeng D, Liu Q, Zhang Q, Seminara D, Minna J, Anderson MW. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet. 2004 Sep;75(3):460-74. [PubMed]
Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, Eisenbarth GS, Rewers M; Diabetes Autoimmunity Study in the Young. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab. 2004 Aug;89(8):3896-902. [PubMed]
Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, Norris JM, Klingensmith GJ, Rewers M; DAISY study. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care. 2004 Jun;27(6):1399-404. [PubMed]
Beilke J, Johnson Z, Kuhl N, Gill RG. A major role for host MHC class I antigen presentation for promoting islet allograft survival. Transplant Proc. 2004 May;36(4):1173-4. [PubMed]
Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004 Apr;36(4):337-8. [PubMed]
Boustead JN, Martin CC, Oeser JK, Svitek CA, Hunter SI, Hutton JC, O'Brien RM. Identification and characterization of a cDNA and the gene encoding the mouse ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein. J Mol Endocrinol. 2004 Feb;32(1):33-53. [PubMed]
Burdick J, Chase HP, Slover RH, Knievel K, Scrimgeour L, Maniatis AK, Klingensmith GJ. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics. 2004 Mar;113(3 Pt 1):e221-4. [PubMed]
Chase HP. A first book for understanding diabetes. 1st ed. Denver: Children's Diabetes Foundation; 2004.
Chase HP. Detection of ketosis and monitoring of diabetic ketoacidosis. Manag Care. 2004 Apr;13(4 Suppl):5-6; discussion 19-21. [PubMed]
Chase HP. Less known but very costly diabetic ketoacidosis (DKA). Health Productivity Manage. 2004 Mar;3(1):31.
Chase HP, Cooper S, Osberg I, Stene LC, Barriga K, Norris J, Eisenbarth GS, Rewers M. Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes. 2004 Oct;53(10):2569-73. [PubMed]
Chase HP, Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network. Diabetes Care. 2004 Mar;27(3):722-6. [PubMed]
Chase HP, Hayward AR, Eisenbarth GS. Clinical trials for the prevention of type 1 diabetes. Adv Exp Med Biol. 2004;552:291-305. [PubMed]
Chase HP, MacKenzie TA, Burdick J, Fiallo-Scharer R, Walravens P, Klingensmith G, Rewers M. Redefining the clinical remission period in children with type 1 diabetes. Pediatr Diabetes. 2004 Mar;5(1):16-9. [PubMed]
Chase HP, Owen S, Gaston J. Guidelines for bolus insulin therapy with CSII. Infusystems USA. 2004;1(1).
Cook NR, Row PE, Davidson HW. Lysosome associated membrane protein 1 (Lamp1) traffics directly from the TGN to early endosomes. Traffic. 2004 Sep;5(9):685-99. [PubMed]
Coulombe M, Gill RG. The immunobiology of pancreatic islet transplantation. Adv Exp Med Biol. 2004;552:154-69. [PubMed]
Cruz TD, Valdes AM, Santiago A, Frazer de Llado T, Raffel LJ, Zeidler A, Rotter JI, Erlich HA, Rewers M, Bugawan T, Noble JA. DPB1 alleles are associated with type 1 diabetes susceptibility in multiple ethnic groups. Diabetes. 2004 Aug;53(8):2158-63. [PubMed]
Cutfield WS, Regan FA, Jackson WE, Jefferies CA, Robinson EM, Harris M, Hofman PL. The endocrine consequences for very low birth weight premature infants. Growth Horm IGF Res. 2004 Jun;14 Suppl A:S130-5. [PubMed]
Davidson HW. (Pro)Insulin processing: a historical perspective. Cell Biochem Biophys. 2004;40(3 Suppl):143-58. [PubMed]
Devendra D, Eisenbarth GS. Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol. 2004 Jun;111(3):225-33. [PubMed]
Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ. 2004 Mar 27;328(7442):750-4. [PubMed]
Devendra D, Paronen J, Liu E, Moriyama H, Miao D, Yu L, Eisenbarth GS. Differential immune induction with subcutaneous versus oral administration of a diabetogenic insulin peptide in the NOD mouse. Ann N Y Acad Sci. 2004 Dec;1029:328-30. [PubMed]
Devendra D, Paronen J, Liu E, Moriyama H, Taylor R, Miao D, Yu L, Eisenbarth G. Comparative study of oral versus subcutaneous B:9-23 insulin peptide in Balb/c mice as an experimental model for autoimmune diabetes. Ann N Y Acad Sci. 2004 Dec;1029:331-3. [PubMed]
Devendra D, Paronen J, Moriyama H, Miao D, Eisenbarth GS, Liu E. Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes. J Autoimmun. 2004 Aug;23(1):17-26. [PubMed]
Devendra D, Yu L, Eisenbarth GS. Endocrine autoantibodies. Clin Lab Med. 2004 Mar;24(1):275-303. [PubMed]
Doyle MJ, Sussel L. Engineering islets: lessons from stem cells and embryonic development. Endocrinol Metab Clin North Am. 2004 Mar;33(1):149-62, x. [PubMed]
Eisenbarth GS. Autoimmune polyendocrine syndromes. Adv Exp Med Biol. 2004;552:204-18. [PubMed]
Eisenbarth GS. Genetic counseling for type 1 diabetes. In: Lebovitz H, editor. Therapy for diabetes mellitus and related disorders. 4th ed. Alexandria, Virginia: American Diabetes Association; 2004.
Eisenbarth GS. Prediction of type 1 diabetes: the natural history of the prediabetic period. Adv Exp Med Biol. 2004;552:268-90. [PubMed]
Eisenbarth GS. Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials. Curr Diab Rep. 2004 Apr;4(2):85-6. [PubMed]
Eisenbarth GS. Type 1 diabetes: molecular, cellular and clinical immunology. Adv Exp Med Biol. 2004;552:306-10. [PubMed]
Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. 2004 May 13;350(20):2068-79. [PubMed]
Eisenbarth GS, Jasinski JM. Disease prevention with islet autoantigens. Endocrinol Metab Clin North Am. 2004 Mar;33(1):59-73, viii. [PubMed]
Eisenbarth SC, Eisenbarth GS. Primer: immunology/autoimmunity. Adv Exp Med Biol. 2004;552:1-15. [PubMed]
Eisenbarth SC, Zhadkevich A, Ranney P, Herrick CA, Bottomly K. IL-4-dependent Th2 collateral priming to inhaled antigens independent of Toll-like receptor 4 and myeloid differentiation factor 88. J Immunol. 2004 Apr 1;172(7):4527-34. [PubMed]
Fiallo-Scharer R, Eisenbarth GS. Pathophysiology of insulin-dependent diabetes. In: Pescovitz OH, Eugster EA, editors. Pediatric endocrinology: mechanisms, manifestations and management. Philadelphia, Pennsylvania: Lippincott, Williams, and Wilkins; 2004.
Frigeri C, Martin CC, Svitek CA, Oeser JK, Hutton JC, Gannon M, O'Brien RM. The proximal islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen promoter is sufficient to initiate but not maintain transgene expression in mouse islets in vivo. Diabetes. 2004 Jul;53(7):1754-64. [PubMed]
Garg S, Chase HP. Treatment of adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2004 May 1;17(5):805-6. [PubMed]
Garg SK. Health impact from frequent and continuous glucose monitoring. Diabetes Technol Ther. 2004 Aug;6(4):523-4. [PubMed]
Garg SK, Carter JA, Mullen L, Folker AC, Parkes JL, Tideman AM. The clinical performance and ease of use of a blood glucose meter that uses a 10-test disk. Diabetes Technol Ther. 2004 Aug;6(4):495-502. [PubMed]
Garg SK, Gottlieb PA, Hisatomi ME, D'Souza A, Walker AJ, Izuora KE, Chase HP. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine. Diabetes Res Clin Pract. 2004 Oct;66(1):49-56. [PubMed]
Garg SK, Hoff HK, Chase HP. The role of continuous glucose sensors in diabetes care. Endocrinol Metab Clin North Am. 2004 Mar;33(1):163-73, x-xi. [PubMed]
Garg SK, Paul JM, Karsten JI, Menditto L, Gottlieb PA. Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes. Diabetes Technol Ther. 2004 Oct;6(5):589-95. [PubMed]
Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care. 2004 Mar;27(3):734-8. [PubMed]
Garg SK, Walker AJ, Hoff HK, D'Souza AO, Gottlieb PA, Chase HP. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. Diabetes Technol Ther. 2004 Feb;6(1):9-15. [PubMed]
Gibney EM, Parikh CR, Jani A, Fischer MJ, Collier D, Wiseman AC. Kidney transplantation for systemic sclerosis improves survival and may modulate disease activity. Am J Transplant. 2004 Dec;4(12):2027-31. [PubMed]
Gottlieb PA. Type 1 diabetes. Endocrinol Metab Clin North Am. 2004 Mar;33(1):xiii-xiv. [PubMed]
Grazia TJ, Pietra BA, Johnson ZA, Kelly BP, Plenter RJ, Gill RG. A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol. 2004 Jun 15;172(12):7451-8. [PubMed]
Groner JA, Wadwa P, Hoshaw-Woodard S, Hayes J, Klein J, Koren, Castile R. Active and passive tobacco smoke exposure: a comparison of maternal and child hair cotinine. Nicotine Tob Res. 2004;6:789-95.
Haskins K. T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones. J Autoimmun. 2004 Mar;22(2):107-9. [PubMed]
Haskins K, Kench J, Powers K, Bradley B, Pugazhenthi S, Reusch J, McDuffie M. Role for oxidative stress in the regeneration of islet beta cells? J Investig Med. 2004 Jan;52(1):45-9. [PubMed]
Hoffenberg EJ, Emery LM, Barriga KJ, Bao F, Taylor J, Eisenbarth GS, Haas JE, Sokol RJ, Taki I, Norris JM, Rewers M. Clinical features of children with screening-identified evidence of celiac disease. Pediatrics. 2004 May;113(5):1254-9. [PubMed]
Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, Cutfield WS. Premature birth and later insulin resistance. N Engl J Med. 2004 Nov 18;351(21):2179-86. Erratum in: N Engl J Med. 2004 Dec 30;351(27):2888. [PubMed]
Hokanson JE, MacKenzie T, Kinney G, Snell-Bergeon JK, Dabelea D, Ehrlich J, Eckel RH, Rewers M. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am J Roentgenol. 2004 May;182(5):1327-32. [PubMed]
Homann D, Gill RG. To help and help not. Nat Immunol. 2004 Sep;5(9):878-80. [PubMed]
Hutton J, Wasmeier C, Amaria R, Bright N, Creemers J. Proprotein processing and pancreatic islet function. Adv Exp Med Biol. 2004;552:39-65. [PubMed]
Jensen J. Gene regulatory factors in pancreatic development. Dev Dyn. 2004 Jan;229(1):176-200. [PubMed]
Johnson Z, Beilke J, Pietra B, Kelly B, Gill RG. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection. Transplant Proc. 2004 May;36(4):1171-2. [PubMed]
Juhl K, Hutton J. Stimulus-secretion coupling in the pancreatic beta-cell. Adv Exp Med Biol. 2004;552:66-90. [PubMed]
Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes. J Immunol. 2004 Mar 15;172(6):3955-62. [PubMed]
Klingensmith G, Kaufman F, Schatz D, Clarke W; American Diabetes Association. Diabetes care in the school and day care setting. Diabetes Care. 2004 Jan;27 Suppl 1:S122-8. [PubMed]
Liu E, Moriyama H, Abiru N, Paronen J, Devendra D, Finkelman FD, Eisenbarth GS. Preventing peptide-induced anaphylaxis: addition of C-terminal amino acids to produce a neutral isoelectric point. J Allergy Clin Immunol. 2004 Sep;114(3):607-13. [PubMed]
Liu E, Yu L, Moriyama H, Eisenbarth GS. Animal models of insulin-dependent diabetes. Methods Mol Med. 2004;102:195-212. [PubMed]
Mauras N, Beck RW, Ruedy KJ, Kollman C, Tamborlane WV, Chase HP, Buckingham BA, Tsalikian E, Weinzimer S, Booth AD, Xing D; Diabetes Research in Children Network (DirecNet) Accuracy Study. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. J Pediatr. 2004 Jun;144(6):770-5. [PubMed]
McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E, Mestroni L; Familial Cardiomyopathy Registry Research Group. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation. 2004 Oct 12;110(15):2163-7. [PubMed]
Melanitou E, Devendra D, Liu E, Miao D, Eisenbarth GS. Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset. J Immunol. 2004 Dec 1;173(11):6603-10. [PubMed]
Mitchell MB, Campbell DN, Ivy D, Boucek MM, Sondheimer HM, Pietra B, Das BB, Coll JR. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg. 2004 Nov;128(5):693-702. [PubMed]
Modiano JF, Sun J, Lang J, Vacano G, Patterson D, Chan D, Franzusoff A, Gianani R, Meech SJ, Duke R, Bellgrau D. Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells. Clin Immunol. 2004 Jul;112(1):54-65. [PubMed]
Nakayama M, Moriyama H, Abiru N, Babu SR, Sikora K, Li M, Miao D, Hutton JC, Elliott JF, Eisenbarth GS: Establishment of native insulin-negative NOD mice and methodology to distinguish specific insulin knockout genotypes and a B:16 alanine preproinsulin transgene. Ann NY Acad Sci. 2004 Dec;1037:193-8. [PubMed]
Nygaard Jensen J, Jensen J. Cell therapy of diabetes. Adv Exp Med Biol. 2004;552:16-38. [PubMed]
Ott PA, Dittrich MT, Herzog BA, Guerkov R, Gottlieb PA, Putnam AL, Durinovic-Bello I, Boehm BO, Tary-Lehmann M, Lehmann PV. T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J Clin Immunol. 2004 Jul;24(4):327-39. [PubMed]
Paronen J, Liu E, Moriyama H, Devendra D, Ide A, Taylor R, Yu L, Miao D, Melanitou E, Eisenbarth GS. Genetic differentiation of poly I:C from B:9-23 peptide induced experimental autoimmune diabetes. J Autoimmun. 2004 Jun;22(4):307-13. [PubMed]
Pauza ME, Dobbs CM, He J, Patterson T, Wagner S, Anobile BS, Bradley BJ, Lo D, Haskins K. T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes. 2004 Apr;53(4):978-88. [PubMed]
Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B, Sussel L. Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2924-9. [PubMed]
Pugliese A, Eisenbarth GS. Type 1 diabetes mellitus of man: genetic susceptibility and resistance. Adv Exp Med Biol. 2004;552:170-203. [PubMed]
Redondo MJ, Fain PR, Krischer JP, Yu L, Cuthbertson D, Winter WE, Eisenbarth GS; DPT-1 Study Group. Expression of beta-cell autoimmunity does not differ between potential dizygotic twins and siblings of patients with type 1 diabetes. J Autoimmun. 2004 Nov;23(3):275-9. [PubMed]
Rewers M, Liu E, Simmons J, Redondo MJ, Hoffenberg EJ. Celiac disease associated with type 1 diabetes mellitus. Endocrinol Metab Clin North Am. 2004 Mar;33(1):197-214, xi. [PubMed]
Rewers M, Norris J, Dabelea D. Epidemiology of type 1 Diabetes Mellitus. Adv Exp Med Biol. 2004;552:219-46. [PubMed]
Rewers M, Zaccaro D, D'Agostino R, Haffner S, Saad MF, Selby JV, Bergman R, Savage P; Insulin Resistance Atherosclerosis Study Investigators. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004 Mar;27(3):781-7. [PubMed]
Rewers M, Zimmet P. The rising tide of childhood type 1 diabetes--what is the elusive environmental trigger? Lancet. 2004 Nov 6;364(9446):1645-7. [PubMed]
Saad MF, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, Zaccaro D, Bergman RN, Savage PJ, Haffner SM. Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension. 2004 Jun;43(6):1324-31. [PubMed]
Sherwin RS, Anderson RM, Buse JB, Chin MH, Eddy D, Fradkin J, Ganiats TG, Ginsberg HN, Kahn R, Nwankwo R, Rewers M, Schlessinger L, Stern M, Vinicor F, Zinman B; American Diabetes Association; National Institute of Diabetes and Digestive and Kidney Diseases. Prevention or delay of type 2 diabetes. Diabetes Care. 2004 Jan;27 Suppl 1:S47-54. [PubMed]
Snell-Bergeon JK, Hokanson JE, Kinney GL, Dabelea D, Ehrlich J, Eckel RH, Ogden L, Rewers M. Measurement of abdominal fat by CT compared to waist circumference and BMI in explaining the presence of coronary calcium. Int J Obes Relat Metab Disord. 2004 Dec;28(12):1594-9. [PubMed]
Stanley HM, Norris JM, Barriga K, Hoffman M, Yu L, Miao D, Erlich HA, Eisenbarth GS, Rewers M; Diabetes Autoimmunity Study in the Young (DAISY). Is presence of islet autoantibodies at birth associated with development of persistent islet autoimmunity? The Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Care. 2004 Feb;27(2):497-502. [PubMed]
Steck AK, Barriga K, Emery L, Fiallo-Scharer R, Gottlieb P, Rewers M. Secondary attack rate of Type 1 diabetes in Colorado families. Diabetes Care. 2005 Feb;28(2):296-300.
Stene LC, Barriga K, Norris JM, Hoffman M, Erlich HA, Eisenbarth GS, McDuffie RS Jr, Rewers M. Perinatal factors and development of islet autoimmunity in early childhood: the diabetes autoimmunity study in the young. Am J Epidemiol. 2004 Jul 1;160(1):3-10. [PubMed]
Tsalikian E, Kollman C, Mauras N, Weinzimer S, Buckingham B, Xing D, Beck R, Ruedy K, Tamborlane W, Fiallo-Scharer R; Diabetes Research in Children Network (DirecNet) Study Group. GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. Diabetes Technol Ther. 2004 Oct;6(5):559-66. [PubMed]
Vendrame F, Gottlieb PA. Prediabetes: prediction and prevention trials. Endocrinol Metab Clin North Am. 2004 Mar;33(1):75-92, ix. [PubMed]
Vo YP, Hutton JC, Angleson JK. Recycling of the dense-core vesicle membrane protein phogrin in Min6 beta-cells. Biochem Biophys Res Commun. 2004 Nov 19;324(3):1004-10. [PubMed]
Wadwa RP, Rewers M: Cardiovascular disease in diabetes: noninvasive detection. Curr Opin Endocrinol Diabetes. 2004;11:70-4.
Wang J, Elghazi L, Parker SE, Kizilocak H, Asano M, Sussel L, Sosa-Pineda B. The concerted activities of Pax4 and Nkx2.2 are essential to initiate pancreatic beta-cell differentiation. Dev Biol. 2004 Feb 1;266(1):178-89. [PubMed]
Weinzimer SA, Tamborlane WV, Chase HP, Garg SK. Continuous glucose monitoring in type 1 diabetes. Curr Diab Rep. 2004 Apr;4(2):95-100. [PubMed]
Westphal CS, McLean JA, Hakspiel SJ, Jackson WE, McClain DE, Montaser A. Determination of depleted uranium in urine via isotope ratio measurements using large-bore direct injection high efficiency nebulizer-inductively coupled plasma mass spectrometry. Appl Spectrosc. 2004 Sep;58(9):1044-50. [PubMed]
Wheat W, Kupfer R, Gutches DG, Rayat GR, Beilke J, Scheinman RI, Wegmann DR. Increased NF-kappa B activity in B cells and bone marrow-derived dendritic cells from NOD mice. Eur J Immunol. 2004 May;34(5):1395-404. [PubMed]
Yu J, Shin CH, Yang SW, Park MH, Eisenbarth GS. Analysis of children with type 1 diabetes in Korea: high prevalence of specific anti-islet autoantibodies, immunogenetic similarities to Western populations with "unique" haplotypes, and lack of discrimination by aspartic acid at position 57 of DQB. Clin Immunol. 2004 Dec;113(3):318-25. [PubMed]
Yu L, Eisenbarth GS. Humoral autoimmunity. Adv Exp Med Biol. 2004;552:247-67. [PubMed]
Zahn TR, Angleson JK, MacMorris MA, Domke E, Hutton JF, Schwartz C, Hutton JC. Dense core vesicle dynamics in Caenorhabditis elegans neurons and the role of kinesin UNC-104. Traffic. 2004 Jul;5(7):544-59. [PubMed]
Zamora MR, Nicolls MR, Hodges TN, Marquesen J, Astor T, Grazia T, Weill D. Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation. Am J Transplant. 2004 Oct;4(10):1635-42. [PubMed]
2003
Abiru N, Sun F, Kawasaki E, Yamasaki H, Oshima K, Nagayama Y, Mizuguchi H, Hayakawa T, Miao D, Liu E, Eisenbarth GS, Eguchi K. In vivo expression of B:9-23 peptide/I-A(g7) complex may abrogate the inhibition of diabetes induced by RGD-fiber-mutant adenovirus in NOD mice. Ann N Y Acad Sci. 2003 Nov;1005:218-21. [PubMed]
Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003 Jun;16(3):208-14. [PubMed]
Babu SR, Bao F, Roberts CM, Martin AK, Gowan K, Eisenbarth GS, Fain PR. Caspase 7 is a positional candidate gene for IDDM 17 in a Bedouin Arab family. Ann N Y Acad Sci. 2003 Nov;1005:340-3. [PubMed]
Bao F, Babu SR, Roberts CM, Martin AK, Gowan K, Eisenbarth GS, Fain PR. Single nucleotide polymorphism study of IDDM 17 in a Bedouin Arab family. Ann N Y Acad Sci. 2003 Nov;1005:348-51. [PubMed]
Barker JM, Eisenbarth GS. The natural history of autoimmunity in type 1A diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM, editors. Diabetes mellitus: a fundamental and clinical text. Philadelphia, Pennsylvania: Lippincott, Williams and Wilkins; 2003.
Chase HP, Dixon B, Pearson J, Fiallo-Scharer R, Walravens P, Klingensmith G, Rewers M, Garg SK. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr. 2003 Dec;143(6):737-40. [PubMed]
Chase HP, Pearson JA, Wightman C, Roberts MD, Oderberg AD, Garg SK. Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care. 2003 May;26(5):1475-9. [PubMed]
Chase HP, Roberts MD, Wightman C, Klingensmith G, Garg SK, Van Wyhe M, Desai S, Harper W, Lopatin M, Bartkowiak M, Tamada J, Eastman RC. Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics. 2003 Apr;111(4 Pt 1):790-4. [PubMed]
Chase HP. Glycemic control in prepubertal years. Diabetes Care. 2003 Apr;26(4):1304-5. [PubMed]
Chase HP. Modem transmission of glucose values reduces the costs of and need for clinic visits: response to Perlemuter and Yomtov. Diabetes Care. 2003 Oct;26(10):2969-70. [PubMed]
Chen LR, Wesley JA, Bhattachar S, Ruiz B, Bahash K, Babu SR. Dissolution behavior of a poorly water soluble compound in the presence of Tween 80. Pharm Res. 2003 May;20(5):797-801. [PubMed]
Cissell MA, Zhao L, Sussel L, Henderson E, Stein R. Transcription factor occupancy of the insulin gene in vivo. Evidence for direct regulation by Nkx2.2. J Biol Chem. 2003 Jan 10;278(2):751-6. [PubMed]
Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M;The Coronary Artery Calcification in Type 1 Diabetes Study. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes. 2003 Nov;52(11):2833-9. [PubMed]
Devendra D, Eisenbarth GS. 17. Immunologic endocrine disorders. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S624-36. [PubMed]
Devendra D, Galloway TS, Horton SJ, Evenden A, Keller U, Wilkin TJ. The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes. Diabetologia. 2003 Jun;46(6):802-9. [PubMed]
Dichmann DS, Miller CP, Jensen J, Scott Heller R, Serup P. Expression and misexpression of members of the FGF and TGF beta families of growth factors in the developing mouse pancreas. Dev Dyn. 2003 Apr;226(4):663-74.
Eastman RC, Leptien AD, Chase HP. Cost-effectiveness of use of the GlucoWatch Biographer in children and adolescents with type 1 diabetes: a preliminary analysis based on a randomized controlled trial. Pediatr Diabetes. 2003 Jun;4(2):82-6. [PubMed]
Eisenbarth GS. Immunopathogenesis of autoimmune endocrine disease for the next generation of experts. In: Gill RG, Harmon JT, Maclaren NK, editors. Immunologically mediated endocrine diseases. Philadelphia: Lippincott, Williams & Wilkins; 2002. Trends Endocrinol Metab. 2003 Sep;14(7):300. Review.
Eisenbarth GS. Insulin autoimmunity: immunogenetics/ immunopathogenesis of type 1A diabetes. Ann N Y Acad Sci. 2003 Nov;1005:109-18. [PubMed]
Eisenbarth GS, Gottlieb P. Immunoedocrinopathy Syndromes. In: Larsen PR, Kronenberg H, Melmed S, Polonsky KS, editors. Williams textbook of endocrinology. 10th ed. Philadelphia: Saunders; 2003.
Eisenbarth GS, Jackson R. Type 1 diabetes mellitus. In: Kahn CR, Weir GC, editors. Joslin's diabetes mellitus. 14th ed. Philadelphia: Lippincott, William & Wilkins; 2003.
Eisenbarth GS, Kotzin BL. Enumerating autoreactive T cells in peripheral blood: a big step in diabetes prediction. J Clin Invest. 2003 Jan;111(2):179-81. [PubMed]
Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, Bennett DC, Spritz RA. A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet. 2003 Jun;72(6):1560-4. [PubMed]
Frias J, Kinney G, Snell-Bergeon J, Garg S, Rewers M. C-Reactive protein is not associated with microalbuminuria in patients with type 1 diabetes. In: Proceedings of the 63rd Scientific Sessions of the American Diabetes Association. June 13-17, 2003, New Orleans, Louisiana, USA. Diabetes. 2003;52 Suppl 1:A479. [PubMed]
Fronczak CM, Baron AE, Chase HP, Ross C, Brady HL, Hoffman M, Eisenbarth GS, Rewers M, Norris JM. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care. 2003 Dec;26(12):3237-42. [PubMed]
Fu H, Qi Y, Tan M, Cai J, Hu X, Liu Z, Jensen J, Qiu M. Molecular mapping of the origin of postnatal spinal cord ependymal cells: evidence that adult ependymal cells are derived from Nkx6.1+ ventral neural progenitor cells. J Comp Neurol. 2003 Feb 10;456(3):237-44.
Garg SK, Frias JP, Anil S, Gottlieb PA, MacKenzie T, Jackson WE. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes. Endocr Pract. 2003 May-Jun;9(3):187-93. [PubMed]
Gianani R, Eisenbarth GS. Autoimmunity to gastrointestinal endocrine cells in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2003 Apr;88(4):1442-4. [PubMed]
Graves PM, Rotbart HA, Nix WA, Pallansch MA, Erlich HA, Norris JM, Hoffman M, Eisenbarth GS, Rewers M. Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract. 2003 Jan;59(1):51-61. [PubMed]
Hald J, Hjorth JP, German MS, Madsen OD, Serup P, Jensen J. Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev Biol. 2003 Aug 15;260(2):426-37.
Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD, Mitchell BD, Norris JM, Rewers M, Saad MF, Stamm E, Wagenknecht LE, Rich SS. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol. 2003 Apr;13(4):211-7. [PubMed]
Hoffenberg EJ, MacKenzie T, Barriga KJ, Eisenbarth GS, Bao F, Haas JE, Erlich H, Bugawan Tl T, Sokol RJ, Taki I, Norris JM, Rewers M. A prospective study of the incidence of childhood celiac disease. J Pediatr. 2003 Sep;143(3):308-14. [PubMed]
Homann D, von Herrath MG. Interfacing dendritic and natural killer cells: a tool for targeted tolerance induction? Transplantation. 2003 Dec 27;76(12):1657-61.
Hutton JC, Eisenbarth GS. A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes. Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8626-8. [PubMed]
Ide A, Eisenbarth GS. Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders. Rev Endocr Metab Disord. 2003 Sep;4(3):243-53. [PubMed]
Jackson RS, Creemers JW, Farooqi IS, Raffin-Sanson ML, Varro A, Dockray GJ, Holst JJ, Brubaker PL, Corvol P, Polonsky KS, Ostrega D, Becker KL, Bertagna X, Hutton JC, White A, Dattani MT, Hussain K, Middleton SJ, Nicole TM, Milla PJ, Lindley KJ, O'Rahilly S. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003 Nov;112(10):1550-60. [PubMed]
Jambal P, Masterson S, Nesterova A, Bouchard R, Bergman B, Hutton JC, Boxer LM, Reusch JE, Pugazhenthi S. Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells. J Biol Chem. 2003 Jun 20;278(25):23055-65. [PubMed]
Kauffman LD, Sokol RJ, Jones RH, Awad JA, Rewers MJ, Norris JM. Urinary F2-isoprostanes in young healthy children at risk for type 1 diabetes mellitus. Free Radic Biol Med. 2003 Sep 15;35(6):551-7. [PubMed]
Klingensmith G, Kaufman F, Schatz D, Clarke W; American Diabetes Association. Care of children with diabetes in the school and day care setting. Diabetes Care. 2003 Jan;26 Suppl 1:S131-5. [PubMed]
Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab. 2003 Jan;88(1):103-8. [PubMed]
Li FX, Zhu JW, Tessem JS, Beilke J, Varella-Garcia M, Jensen J, Hogan CJ, DeGregori J. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12935-40. [PubMed]
Liggins C, Orlicky DJ, Bloomquist LA, Gianani R. Developmentally regulated expression of Survivin in human pancreatic islets. Pediatr Dev Pathol. 2003 Sep-Oct;6(5):392-7. [PubMed]
Liu E, Bao F, Barriga K, Miao D, Yu L, Erlich HA, Haas JE, Eisenbarth GS, Rewers MJ, Hoffenberg EJ. Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease. Clin Gastroenterol Hepatol. 2003 Sep;1(5):356-62. [PubMed]
Liu E, Moriyama H, Paronen J, Abiru N, Miao D, Yu L, Taylor RM, Eisenbarth GS. Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse. J Autoimmun. 2003 Nov;21(3):213-9. [PubMed]
Maniatis AK, Eisenbarth GS. Prediction and Prevention of Type 1 Diabetes. In: Sperling MA, editor. Contemporary endocrinology: Type 1 diabetes: etiology and treatment. Totowa: Humana Press; 2003.
Melanitou E, Fain P, Eisenbarth GS. Genetics of type 1A (immune mediated) diabetes. J Autoimmun. 2003 Sep;21(2):93-8. [PubMed]
Melanitou E, Liu E, Miao D, Yu L, Glimcher LH, Eisenbarth G. Absence of the T-bet gene coding for the Th1-related transcription factor does not affect diabetes-associated phenotypes in Balb/c mice. Ann N Y Acad Sci. 2003 Nov;1005:187-91. [PubMed]
Mitchell MB, Campbell DN, Boucek MM, Sondheimer HM, Chan KC, Ivy DD, Pietra B, Mackenzie T. Mechanical limitation of pulmonary blood flow facilitates heart transplantation in older infants with hypoplastic left heart syndrome. Eur J Cardiothorac Surg. 2003 May;23(5):735-42. [PubMed]
Moriyama H, Abiru N, Paronen J, Sikora K, Liu E, Miao D, Devendra D, Beilke J, Gianani R, Gill RG, Eisenbarth GS. Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10376-81. [PubMed]
Nadeau K, Klingensmith G, Sokol RJ. Case report: nonalcoholic steatohepatitis in a teenage girl with type 2 diabetes. Curr Opin Pediatr. 2003 Feb;15(1):127-31. [PubMed]
Nicolls MR, D'Antonio JM, Hutton JC, Gill RG, Czwornog JL, Duncan MW. Proteomics as a tool for discovery: proteins implicated in Alzheimer's disease are highly expressed in normal pancreatic islets. J Proteome Res. 2003 Mar-Apr;2(2):199-205. [PubMed]
Nigam R, Bhatia E, Miao D, Yu L, Brozzetti A, Eisenbarth GS, Falorni A. Prevalence of adrenal antibodies in Addison's disease among north Indian Caucasians. Clin Endocrinol (Oxf). 2003 Nov;59(5):593-8. [PubMed]
Norgaard GA, Jensen JN, Jensen J. FGF10 signaling maintains the pancreatic progenitor cell state revealing a novel role of Notch in organ development. Dev Biol. 2003 Dec 15;264(2):323-38. [PubMed]
Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, Rewers M. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA. 2003 Oct 1;290(13):1713-20. [PubMed]
Paronen J, Moriyama H, Abiru N, Sikora K, Melanitou E, Babu S, Bao F, Liu E, Miao D, Eisenbarth GS. Establishing insulin 1 and insulin 2 knockout congenic strains on NOD genetic background. Ann N Y Acad Sci. 2003 Nov;1005:205-10. [PubMed]
Parrish LA, Marshall JA, Krebs NF, Rewers M, Norris JM. Validation of a food frequency questionnaire in preschool children. Epidemiology. 2003 Mar;14(2):213-7. [PubMed]
Pietra B, Boucek M. Coronary artery vasculopathy in pediatric cardiac transplant patients: the therapeutic potential of immunomodulators. Paediatr Drugs. 2003;5(8):513-24. [PubMed]
Pietra BA. Transplantation immunology 2003: simplified approach. Pediatr Clin North Am. 2003 Dec;50(6):1233-59. [PubMed]
Pinhas-Hamiel O, Zeitler P. Barriers to the treatment of adolescent type 2 diabetes--a survey of provider perceptions. Pediatr Diabetes. 2003 Mar;4(1):24-8. [PubMed]
Rayat GR, Gill RG. Pancreatic islet xenotransplantation: barriers and prospects. Curr Diab Rep. 2003 Aug;3(4):336-43. [PubMed]
Rayat GR, Johnson ZA, Beilke JN, Korbutt GS, Rajotte RV, Gill RG. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Diabetes. 2003 Jun;52(6):1433-40. [PubMed]
Rayat GR, Rajotte RV, Hering BJ, Binette TM, Korbutt GS. In vitro and in vivo expression of Galalpha-(1,3)Gal on porcine islet cells is age dependent. J Endocrinol. 2003 Apr;177(1):127-35. [PubMed]
Rayat GR, Rajotte RV, Lyon JG, Dufour JM, Hacquoil BV, Korbutt GS. Immunization with streptozotocin-treated NOD mouse islets inhibits the onset of autoimmune diabetes in NOD mice. J Autoimmun. 2003 Aug;21(1):11-5. [PubMed]
Rewers A, Babu S, Wang TB, Bugawan TL, Barriga K, Eisenbarth GS, Erlich HA. Ethnic differences in the associations between the HLA-DRB1*04 subtypes and type 1 diabetes. Ann N Y Acad Sci. 2003 Nov;1005:301-9. [PubMed]
Robles DT, Eisenbarth GS, Dailey NJ, Peterson LB, Wicker LS. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice. Diabetes. 2003 Mar;52(3):882-6. [PubMed]
Sanjeevi CB, Eisenbarth GS. Preface. Ann N Y Acad Sci. 2003 Nov;1005:1.
Santoshi N, Nilesh P, Prakash S, Devendra D, Anand J, Srinivas V. A novel technique for ureteric access in ileal conduits. BJU Int. 2003 Mar;91(4):423-4. [PubMed]
Schwenke DC, D'Agostino RB Jr, Goff DC Jr, Karter AJ, Rewers MJ, Wagenknecht LE;Insulin resistance atherosclerosis study. Differences in LDL oxidizability by glycemic status: the insulin resistance atherosclerosis study. Diabetes Care. 2003 May;26(5):1449-55. [PubMed]
Sherwin RS, Anderson RM, Buse JB, Chin MH, Eddy D, Fradkin J, Ganiats TG, Ginsberg H, Kahn R, Nwankwo R, Rewers M, Schlessinger L, Stern M, Vinicor F, Zinman B;American Diabetes Association. The prevention or delay of type 2 diabetes. Diabetes Care. 2003 Jan;26 Suppl 1:S62-9. [PubMed]
Snell-Bergeon JK, Hokanson JE, Jensen L, MacKenzie T, Kinney G, Dabelea D, Eckel RH, Ehrlich J, Garg S, Rewers M. Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control. Diabetes Care. 2003 Oct;26(10):2923-8. [PubMed]
Steelman J, Zeitler P. Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J Pediatr. 2003 Apr;142(4):417-23. [PubMed]
Stene LC, Barriga K, Norris JM, Hoffman M, Klingensmith G, Erlich HA, Eisenbarth GS, Rewers M. Symptoms of common maternal infections in pregnancy and risk of islet autoimmunity in early childhood. Diabetes Care. 2003 Nov;26(11):3136-41. [PubMed]
Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WL, Stetler GL, Muntoni F, Bristow MR, Mestroni L; Familial Dilated Cardiomyopathy Registry Research Group. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol. 2003 Mar 5;41(5):771-80. Erratum in: J Am Coll Cardiol. 2003 Aug 6;42(3):590. [PubMed]
The Diabetes Research in Children Network (DirecNet) Study Group [Chase HP, Study Group Member]. A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type 1 diabetes. Diabetes Technol Ther. 2003;5(6):933-41. [PubMed]
The Diabetes Research in Children Network (DirecNet) Study Group [Chase HP, Study Group Member]. The accuracy of the CGMS in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) Accuracy Study. Diabetes Technol Ther. 2003;5(5):781-9. [PubMed]
The Diabetes Research in Children Network (DirecNet) Study Group [Chase, H. Peter - Study Group Member]. The accuracy of the GlucoWatch G2 Biographer in children with type 1 diabetes: results of the Diabetes Research in Children Network (DirecNet) accuracy study. Diabetes Technol Ther. 2003;5(5):791-800. [PubMed]
Tiberti C, Bao F, Bonamico M, Verrienti A, Picarelli A, Di Tola M, Ferri M, Vecci E, Dotta F, Eisenbarth GS, Di Mario U. Celiac disease-associated transglutaminase autoantibody target domains at diagnosis are age and sex dependent. Clin Immunol. 2003 Dec;109(3):318-24. [PubMed]
Vaitaitis GM, Poulin M, Sanderson RJ, Haskins K, Wagner DH Jr. Cutting edge: CD40-induced expression of recombination activating gene (RAG) 1 and RAG2: a mechanism for the generation of autoaggressive T cells in the periphery. J Immunol. 2003 Apr 1;170(7):3455-9. [PubMed]
Wadwa RP, Rose SR, Eaton ME. The Fanconi Anemia Comprehensive Care Center, Endocrine effects of Fanconi Anemia. In: Proceedings of the Pediatric Academic Societies' Annual Meeting. May 3-6, 2003. Seattle, Washington, USA. Pediatr Res. 2003 Apr;53(4 Pt 2):149A. [PubMed]
Wiseman AC, Kam I, Christians U, Jani A, Bak T, Wachs M, Chan L. Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience. Transplant Proc. 2003 May;35(3 Suppl):122S-124S. [PubMed]
Yu L, Eisenbarth G, Bonifacio E, Thomas J, Atkinson M, Wasserfall C. The second murine autoantibody workshop: remarkable interlaboratory concordance for radiobinding assays to identify insulin autoantibodies in nonobese diabetic mice. Ann N Y Acad Sci. 2003 Nov;1005:1-12. [PubMed]
Zeitler PS, Travers SH, Barker J, Nadeau K, Kappy MS. Endocrine disorders. In: Hay WW Jr., Hayward AR, Levin MJ, Sondheimer JM, editors. Current pediatric diagnosis and treatment. 16th ed. New York, New York: McGraw-Hill; 2003.
2002
Achenbach P, Kelemen K, Wegmann DR, Hutton JC. Spontaneous peripheral T-cell responses to the IA-2beta (phogrin) autoantigen in young nonobese diabetic mice. J Autoimmun. 2002 Nov;19(3):111-6. [PubMed]
Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, Fox A, Miller C, Dills DG, Ridgway EC, Bennett DC, Fain PR, Spritz RA. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome1p31.3-p32.2. Hum Mol Genet. 2002 Mar 15;11(6):661-7. [PubMed]
Alleva DG, Gaur A, Jin L, Wegmann D, Gottlieb PA, Pahuja A, Johnson EB, Motheral T, Putnam A, Crowe PD, Ling N, Boehme SA, Conlon PJ. Immunological characterization and therapeutic activity of an altered-peptideligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes. 2002 Jul;51(7):2126-34. [PubMed]
Bellgrau D. Can getting excited over nothing provoke autoimmunity? In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Bergholdt R, Heding P, Nielsen K, Nolsøe R, Sparre T, Størling J, Nerup J, Pociot F, Mandrup-Poulsen T. Type 1 diabetes mellitus: an inflammatory disease of the islet. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Bright NA, Wasmeier C, Walters J and Hutton JC. Targeting of a phogrin-green fluorescent protein chimaera to insulin secretory granules of pancreatic Beta-cells in transgenic mice. Diabetes Metab. 2002 Dec;28(6 Pt 2):3S29-36.
Chase HP, Hayward AR, Eisenbarth GS. Clinical trials for the prevention of type 1 diabetes. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Chase HP, Saib SZ, MacKenzie T, Hansen MM, Garg SK. Postprandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes. Diabet Med. 2002 Apr;19(4):317-21. [PubMed]
Coulombe M, Gill RG. The immunobiology of pancreatic islet transplantation. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Diabetes Prevention Trial - Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002 May 30;346(22):1685-91. [PubMed]
Eastman RC, Chase HP, Buckingham B, Hathout EH, Fuller-Byk L, Leptien A, Van Wyhe MM, Davis TL, Fermi SJ, Pechler H, Sahyun G, Lopatin M, Wayn BY, Wei C, Bartkowiak M, Ginsberg BH, Tamada JA, Pitzer KR. Use of the GlucoWatch biographer in children and adolescents with diabetes. Pediatr Diabetes. 2002;3:127-34.
Eisenbarth GS, editor. Autoimmune polyendocrine syndromes. Endocrinology and metabolism clinics of North America (31). Philadelphia: W.B. Saunders Company; 2002.
Eisenbarth GS. Autoimmune polyendocrine syndromes. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Eisenbarth GS, editor. Immunology of type 1 diabetes, molecular cellular and clinical immunology. 2nd ed. 2002. www.barbaradaviscenter.org
Eisenbarth GS. Pathogenesis of type 1A diabetes. 2002. www.endotext.org
Eisenbarth GS. Prediction of type 1 diabetes: the natural history of the prediabetic period. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology; 2002. www.barbaradaviscenter.org
Eisenbarth GS. Type 1 diabetes: molecular, cellular and clinical immunology. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Eisenbarth GS, Nepom GT. Class II peptide multimers: promise for type 1A diabetes? Nat Immunol. 2002 Apr;3(4):344-5. [PubMed]
Eisenbarth SC, Eisenbarth GS. Primer: immunology/autoimmunity. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Fain P, Eisenbarth GS. Genetics of type 1 diabetes mellitus. In: Baxter JD, Melmed S, New MI, editors. Genetics in endocrinology. Philadelphia: Lippincott Williams & Wilkins; 2002.
Farilla L, Tiberti C, Luzzago A, Yu L, Eisenbarth GS, Cortese R, Dotta F, Di Mario U. Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes. Eur J Immunol. 2002 May;32(5):1420-7. [PubMed]
Gottlieb PA, Eisenbarth GS. Insulin-specific tolerance in diabetes. Clin Immunol. 2002 Jan;102(1):2-11. [PubMed]
Gottlieb PA, Frias JP, Peters KA, Chillara B, Garg SK. Optimizing insulin therapy in pregnant women with type 1 diabetes mellitus. Treat Endocrinol. 2002;1(4):235-40.
Gottlieb PA, Hayward AR. Cytokine and immunosuppressive therapies of type 1 diabetes mellitus. Endocrinol Metab Clin North Am. 2002 Jun;31(2):477-95. [PubMed]
Greeley SA, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, Barker CF, Naji A, Noorchashm H. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med. 2002 Apr;8(4):399-402. [PubMed]
Guest PC, Abdel-Halim SM, Gross DJ, Clark A, Poitout V, Amaria R, Ostenson CG, Hutton JC. Proinsulin processing in the diabetic Goto-Kakizaki rat. J Endocrinol. 2002 Dec;175(3):637-47. [PubMed]
Hokanson JE, Cheng S, Snell-Bergeon JK, Fijal BA, Grow MA, Hung C, Erlich HA, Ehrlich J, Eckel RH, Rewers M. A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes. Diabetes. 2002 Apr;51(4):1208-13. [PubMed]
Jackson W. Improving diabetic retinopathy screening. Diabetes Care. 2002 Aug;25(8):1477-8. [PubMed]
Jensen JN, Jensen J. Cell therapy of diabetes. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Hutton J, Juhl K. The stimulus secretion coupling of insulin secretion. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Hutton J, Wasmeier T, Amaria R, Bright N, Creemers J. Proprotein processing and pancreatic islet function. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Kelemen K. The role of T-cells in beta cell damage in NOD mice and humans. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Klingensmith GK, Temple-Trujillo R, Johnson D. Pump therapy for children: weighing the risks and benefits, view 1: the cons of insulin pump therapy in the young child. Am Diabetes Assoc Ann Rev Diabetes. 2002:152-4.
Lang J, Bellgrau D. Animal models of type 1 diabetes: genetics and immunological function. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Liu E, Abiru N, Moriyama H, Miao D, Eisenbarth GS. Induction of insulin autoantibodies and protection from diabetes with subcutaneous insulin B:9-23 peptide without adjuvant. Ann N Y Acad Sci. 2002 Apr;958:224-7. [PubMed]
Liu E, Eisenbarth GS. Type 1A diabetes mellitus-associated autoimmunity. Endocrinol Metab Clin North Am. 2002 Jun;31(2):391-410, vii-viii. [PubMed]
Liu E, Moriyama H, Abiru N, Miao D, Yu L, Taylor RM, Finkelman FD, Eisenbarth GS. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23. J Clin Invest. 2002 Oct;110(7):1021-7. [PubMed]
Martin CC, Oeser JK, Svitek CA, Hunter SI, Hutton JC, O'Brien RM. Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein. J Mol Endocrinol. 2002 Oct;29(2):205-22. [PubMed]
Miao D, Yu L, Tiberti C, Cuthbertson DD, Rewers M, di Mario U, Eisenbarth GS, Dotta F. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies. J Autoimmun. 2002 Mar;18(2):191-6. [PubMed]
Moriyama H, Wen L, Abiru N, Liu E, Yu L, Miao D, Gianani R, Wong FS, Eisenbarth GS. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5539-44. [PubMed]
Nicolls MR, Coulombe M, Beilke J, Gelhaus HC, Gill RG. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J Immunol. 2002 Nov 1;169(9):4831-9. [PubMed]
Nicolls MR, Coulombe M, Diamond AS, Beilke J, Gill RG. Interferon-gamma is not a universal requirement for islet allograft survival. Transplantation. 2002 Aug 27;74(4):472-7. [PubMed]
Park YS, Sanjeevi CB, Robles D, Yu L, Rewers M, Gottlieb PA, Fain P, Eisenbarth GS. Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease. Tissue Antigens. 2002 Aug;60(2):155-63. [PubMed]
Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B, Kachadourian R, Young R, Bradley B, Haskins K. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes. 2002 Feb;51(2):347-55. [PubMed]
Pugliese A, Eisenbarth GS. Type 1 diabetes mellitus of man: genetic susceptibility and resistance. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Redondo MJ, Eisenbarth GS. Genetic control of autoimmunity in Type I diabetes and associated disorders. Diabetologia. 2002 May;45(5):605-22. [PubMed]
Rewers M. Islet autoantibodies in cord blood: maternal, fetal, or neither? Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):2-4. [PubMed]
Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, Hamman RF, Klingensmith G. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002 May 15;287(19):2511-8. [PubMed]
Rewers M, Norris J, Dabelea D. Epidemiology of type 1 diabetes mellitus. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Robles DT, Eisenbarth GS. Immunology primer. Endocrinol Metab Clin North Am. 2002 Jun;31(2):261-82. [PubMed]
Robles DT, Eisenbarth GS, Wang T, Erlich HA, Bugawan TL, Babu SR, Barriga K, Norris JM, Hoffman M, Klingensmith G, Yu L, Rewers M. Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies. Clin Immunol. 2002 Mar;102(3):217-24. [PubMed]
Robles DT, Fain PR, Gottlieb PA, Eisenbarth GS. The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am. 2002 Jun;31(2):353-68, vi-vii. [PubMed]
Sarkar SA, Sharma RP. All-trans-retinoic acid-mediated modulation of p53 during neural differentiation in murine embryonic stem cells. Cell Biol Toxicol. 2002;18(4):243-57. [PubMed]
Sarkar SA, Sharma RP. Expression of c-Myc and other apoptosis-related genes in Swiss Webster mouse fetuses after maternal exposure to all trans-retinoic acid. Reprod Toxicol. 2002 May-Jun;16(3):245-52. [PubMed]
Sarkar SA, Sharma RP. Expression of selected apoptosis related genes, MIF, IGIF and TNF alpha, during retinoic acid-induced neural differentiation in murine embryonic stem cells. Cell Struct Funct. 2002 Apr;27(2):99-107. [PubMed]
Sarkar SA, Sharma RP. Modulation of c-myc, max, and mad gene expression during neural differentiation of embryonic stem cells by all-trans-retinoic acid. Gene Expr. 2002;10(3):125-35. [PubMed]
Serreze DV, Roopenian DC. Was there type 1 diabetes in the Olduvai Gorge? In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Sherwin R, Anderson R, Buse J, Chin M, Fradkin J, Ganiats T, Ginsburg H, Kahn R, Nwanko R, Rewers M, Stern M, Vinicor F, Zinman B. The prevention or delay of type 2 diabetes. Diabetes Care. 2002 Apr;25(4):742-9. [PubMed]
Swenson CJ, Trepka MJ, Rewers MJ, Scarbro S, Hiatt WR, Hamman RF. Cardiovascular disease mortality in Hispanics and non-Hispanic whites. Am J Epidemiol. 2002 Nov 15;156(10):919-28. [PubMed]
von Herrath, Matthias G. Pathogenesis of type 1 diabetes - a viewpoint. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Wagner DH Jr., Vaitaitis G, Sanderson R, Poulin M, Dobbs C, Haskins K. Expression of CD40 identifies a unique pathogenic T-cell population in type 1 diabetes. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3782-7. [PubMed]
Wasmeier C, Bright NA, Hutton JC. The lumenal domain of the integral membrane protein phogrin mediates targeting to secretory granules. Traffic. 2002 Sep;3(9):654-65. [PubMed]
Yoshida K, Martin T, Yamamoto K, Dobbs C, Munz C, Kamikawaji N, Nakano N, Rammensee HG, Sasazuki T, Haskins K, Kikutani H. Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T-cell clones. Int Immunol. 2002 Dec;14(12):1439-47. [PubMed]
Yu L, Cuthbertson DD, Eisenbarth GS, Krischer JP. Diabetes prevention trial 1: prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband. Ann N Y Acad Sci. 2002 Apr;958:254-8. [PubMed]
Yu L, Eisenbarth GS. Humoral autoimmunity. In: Eisenbarth G, editor. Type 1 diabetes: molecular cellular and clinical immunology. 2002. www.barbaradaviscenter.org
Zeitler P, Siriwardana G. Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells. Endocrine. 2002 Jun;18(1):85-90. [PubMed]
2001
Abiru N, Maniatis AK, Yu L, Miao D, Moriyama H, Wegmann D, Eisenbarth GS. Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice. Diabetes. 2001 Jun;50(6):1274-81. [PubMed]
Abiru N, Yu L, Miao D, Maniatis AK, Liu E, Moriyama H, Eisenbarth GS. Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains. J Autoimmun. 2001 Aug;17(1):1-6. [PubMed]
Anderson MS, Burns J, Treadwell TA, Pietra BA, Glodé MP. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J. 2001 Jul;20(7):698-702. [PubMed]
Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001 Jul 21;358(9277):221-9. [PubMed]
Babu S, Walravens P, Simone E, Kawasaki E, Wang T, Yu L, Chase HP, Rewers M, Klingensmith G, Eisenbarth GS. Is type 2 diabetes in children increasing: one half of African and Hispanic-American children do not have type 2 diabetes. In: Kapu A, Joshi JK, editors. Proceedings of the Tenth Novo Nordisk Update; 2001 Feb 17; Chennai, India: Communication Workshop, Ltd.
Bingley PJ, Bonifacio E, Ziegler AG, Schatz DA, Atkinson MA, Eisenbarth GS. Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care. 2001 Feb;24(2):398. [PubMed]
Bischof LJ, Martin CC, Svitek CA, Stadelmaier BT, Hornbuckle LA, Goldman JK, Oeser JK, Hutton JC, O'Brien RM. Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting: correlation with fusion gene expression in the islet-derived betaTC-3 and hamster insulinoma tumor cell lines. Diabetes. 2001 Mar;50(3):502-14. [PubMed]
Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes. 2001 Nov;50(11):2451-8. [PubMed]
Boucek MM, Sondheimer HM, Ivy DD, Shaffer EM, Mashburn C, Ripe DW, Gilbert DJ, Kyle TE, Campbell DN, Pietra B. Transplant coronary artery disease in pediatrics: favorable outcome with medical therapy. J Heart Lung Transplant. 2001 Feb;20(2):261. |
